Clinical Trial Update: Predicting Cardiometabolic Risk in Mild-to-Moderate Obstructive Sleep Apnea: Inflammation vs. Apnea/Hypopnea Index

View source ↗

Summary

An ongoing clinical trial is evaluating whether inflammatory markers or the apnea-hypopnea index better predict cardiometabolic risk in adults with mild-to-mode…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Obstructive Sleep Apnea

Snippet

Sponsor: Milton S. Hershey Medical Center | Conditions: Obstructive Sleep Apnea | Status: ENROLLING_BY_INVITATION